Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Frontiers in Immunology|June 9, 2015
Adoptive T Cell Therapy Targeting CD1 and MR1Tingxi Guo, Kenji Chamoto, Naoto HiranoACS Synthetic Biology|March 22, 2022
Sense-and-Respond Payload Delivery Using a Novel Antigen-Inducible Promoter Improves Suboptimal CAR-T ActivationTingxi Guo, Dacheng Ma, Timothy K LuPlos One|May 24, 2016
Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell ReceptorsTingxi Guo, Kenji Chamoto, Munehide Nakatsugawa, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2015
Specific roles of each TCR hemichain in generating functional chain-centric TCRMunehide Nakatsugawa, Yuki Yamashita, Toshiki Ochi, et al.JCI Insight|February 1, 2017
Transient stimulation expands superior antitumor T cells for adoptive therapyYuki Kagoya, Munehide Nakatsugawa, Toshiki Ochi, et al.Nature Reviews. Drug Discovery|October 7, 2021
Engineering living therapeutics with synthetic biologyAndres Cubillos-Ruiz, Tingxi Guo, Anna Sokolovska, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2017
A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1<sup>+</sup> TCRsTingxi Guo, Ming Yin Koo, Yuki Kagoya, et al.Cancer Immunology Research|May 7, 2015
Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene TherapyToshiki Ochi, Munehide Nakatsugawa, Kenji Chamoto, et al.Nature Communications|May 17, 2018
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy modelsYuki Kagoya, Munehide Nakatsugawa, Kayoko Saso, et al.Nature Medicine|February 6, 2018
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effectsYuki Kagoya, Shinya Tanaka, Tingxi Guo, et al.Pageof 3